Skip to content

Clinical trials

Observational Burns trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Burns Phase: Observational Clear all

159 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20021
20032
20042
20054
20062
20074
20084
20094
20105
20114
20121
20134
20147
20156
20169
201711
20189
201910
20209
20218
202210
20237
20245
202513
20269

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed78
Unknown status20
Recruiting18
Withdrawn15
Terminated12
Not yet recruiting8
Active, not recruiting6
Suspended1
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Massachusetts General Hospital10
The University of Texas Medical Branch, Galveston5
Assistance Publique - Hôpitaux de Paris4
SpectralMD4
Chelsea and Westminster NHS Foundation Trust3
Shriners Hospitals for Children3
University of California, Irvine3
University of North Carolina, Chapel Hill3
American Burn Association2
Anterogen Co., Ltd.2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Burns159
Wounds and Injuries14
Critical Illness9
Sepsis7
Cicatrix6
Inflammation6
Infections5
Pressure Ulcer5
Respiratory Distress Syndrome5
Multiple Organ Failure4

Trials

Showing 76 to 100 of 159. Each trial links to its page on Pharma Observatory.

59 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.